These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9000257)
1. Pharmacological analysis of local anaesthetic tolycaine-induced convulsions by modification of monoamines in rat brain. Satoh T; Sawaki K; Kawaguchi M Pharmacol Toxicol; 1996 Dec; 79(6):305-11. PubMed ID: 9000257 [TBL] [Abstract][Full Text] [Related]
2. Alterations of lidocaine and pentylenetetrazol-induced convulsions by manipulation of brain monoamines. Abed WT Pharmacol Toxicol; 1994; 75(3-4):162-5. PubMed ID: 7800657 [TBL] [Abstract][Full Text] [Related]
3. Some correlations between procaine-induced convulsions and monoamines in the spinal cord of rats. Sawaki K; Kawaguchi M Jpn J Pharmacol; 1989 Nov; 51(3):369-76. PubMed ID: 2622091 [TBL] [Abstract][Full Text] [Related]
4. Brain norepinephrine reductions in soman-intoxicated rats: association with convulsions and AChE inhibition, time course, and relation to other monoamines. el-Etri MM; Nickell WT; Ennis M; Skau KA; Shipley MT Exp Neurol; 1992 Nov; 118(2):153-63. PubMed ID: 1426125 [TBL] [Abstract][Full Text] [Related]
5. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone. Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968 [TBL] [Abstract][Full Text] [Related]
6. Effect of guanidinoethanesulfonic acid on brain monoamines in the mouse. Watanabe Y; Watanabe S; Yokoi I; Mori A Neurochem Res; 1991 Oct; 16(10):1149-54. PubMed ID: 1724553 [TBL] [Abstract][Full Text] [Related]
7. [The role of mediators in the genesis of convulsive activity. Biogenic monoamine content of the brain of rats with various predispositions to audiogenic convulsions]. Sergienko NG; Loginova GA Vopr Med Khim; 1983; 29(6):21-4. PubMed ID: 6142564 [TBL] [Abstract][Full Text] [Related]
8. Effects of anticonvulsants on local anaesthetic-induced neurotoxicity in rats. Sawaki K; Ohno K; Miyamoto K; Hirai S; Yazaki K; Kawaguchi M Pharmacol Toxicol; 2000 Feb; 86(2):59-62. PubMed ID: 10728915 [TBL] [Abstract][Full Text] [Related]
9. Effects of delayed treatment with nafronyl oxalate on microsphere embolism-induced changes in monoamine levels of rat brain regions. Takagi N; Miyake K; Ohiwa A; Nukaga R; Takeo S Br J Pharmacol; 1996 May; 118(1):33-40. PubMed ID: 8733573 [TBL] [Abstract][Full Text] [Related]
10. Propranolol increases the threshold for lidocaine-induced convulsions in awake rats: a direct effect on the brain. Nakamura T; Oda Y; Takahashi R; Tanaka K; Hase I; Asada A Anesth Analg; 2008 May; 106(5):1450-5, table of contents. PubMed ID: 18420859 [TBL] [Abstract][Full Text] [Related]
11. Uptake of monoamines into central neurones and the blood-brain barrier in the infant rat. Loizou LA Br J Pharmacol; 1970 Dec; 40(4):800-13. PubMed ID: 5495178 [TBL] [Abstract][Full Text] [Related]
12. Nicotine-induced convulsions in cats and central nicotinic receptors. Beleslin DB; Krstić SK Pharmacol Biochem Behav; 1986 Jun; 24(6):1509-11. PubMed ID: 2874565 [TBL] [Abstract][Full Text] [Related]
13. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain. Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313 [TBL] [Abstract][Full Text] [Related]
15. [Monoamine level in the rat brain with MPTP-induced depressive syndrome]. Popkova EV; Krupina NA; Kryzhanovskiĭ GN; Orlova IN; Iordanskaia TE Biull Eksp Biol Med; 1999 Jan; 127(1):24-9. PubMed ID: 10189998 [No Abstract] [Full Text] [Related]
16. The effect of chronic chlorpromazine administration on monoamine levels in various regions of rat brain. Baf MH; Subhash MN; Lakshmana KM; Rao BS Neurochem Res; 1995 Jan; 20(1):51-4. PubMed ID: 7739759 [TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with D1 and D2 dopamine receptor agonists: combined treatments interact to differentially affect brain levels of monoamines. Martin-Iverson MT Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):281-5. PubMed ID: 1683687 [TBL] [Abstract][Full Text] [Related]